Thermo Fisher Scientific Inc., US8835561023

Morgan Stanley raises target for Thermo Fisher Scientific stock to USD 730

Published on 10/13/2026 at 15:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 21, 2026. Thermo Fisher Scientific stock costs EUR 591.40 in trading on October 13, 2026, down 0.24 percent on NYSE.

Analyst targets and reporting date

  • Morgan Stanley raised its Thermo Fisher Scientific target from USD 650.00 to USD 730.00 on October 12, 2026.
  • Thermo Fisher Scientific plans to release third-quarter 2026 results on October 21, 2026.
  • Thermo Fisher Scientific stock costs EUR 591.40 at Lang & Schwarz on October 13, 2026 at 5:31 p.m. CEST, down 0.24 percent on the NYSE versus USD 662.24 on October 12, 2026.
  • Thermo Fisher Scientific had a USD 244.3 billion market capitalization and a P/E ratio of 35.51 on October 13, 2026.
Isometrische Illustration einer Biotech-Wertschöpfungskette mit Labor, Fabrik und Lieferwagen
Isometrische 3D-Grafik zeigt Thermo Fisher Sci. US8835561023 als Wertschöpfungskette von Labor, Produktion bis Auslieferung, Illustration mit AI erstellt.

As Markets Insider reported on October 12, 2026, Morgan Stanley raised its Thermo Fisher Scientific target to USD 730.00 from USD 650.00 and kept an Overweight rating. Against the NYSE price of USD 660.67 at 9:35 a.m. ET on October 13, 2026, the target lies 10.50 percent above the price. At Lang & Schwarz, the stock was trading at EUR 591.40 on October 13, 2026 at 5:31 p.m. CEST.

Results date is October 21

Thermo Fisher Scientific has scheduled its third-quarter 2026 earnings call for October 21, 2026 at 7:00 a.m. ET. The event is less than two weeks away, placing the analyst target against an imminent results update.

Stock stays below yearly high

On the NYSE, Thermo Fisher Scientific traded at USD 660.67 on October 13, 2026, or 4.85 percent below its 52-week high of USD 694.33. Its 52-week low was USD 435.27, while volume stood at 29,917 shares against an average volume of 2,094,123 shares on the same date.

The current NYSE price was down 0.24 percent from USD 662.24 on October 12, 2026. The move is measured separately from the euro quote at Lang & Schwarz, which gives German investors a different currency view of the same session.

Valuation and trading date

Thermo Fisher Scientific had a USD 244.3 billion market capitalization and a P/E ratio of 35.51 on October 13, 2026. The company is identified as NYSE: TMO in its official investor notice.

Comparison with peers

Thermo Fisher Scientific: minus 0.24 percent, P/E 35.51, market capitalization USD 244.3 billion
Danaher (NYSE, USD): plus 0.42 percent, P/E 39.35, market capitalization USD 156.2 billion
Agilent Technologies (NYSE, USD): minus 0.01 percent, P/E 33.86, market capitalization USD 48.4 billion

Price remains the market frame

At Lang & Schwarz, Thermo Fisher Scientific stock was trading at EUR 591.40 on October 13, 2026 at 5:31 p.m. CEST. On the NYSE, it stood at USD 660.67 at 9:35 a.m. ET, down 0.24 percent versus USD 662.24 on October 12, 2026. The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.

Thermo Fisher Scientific market data

  • Company: Thermo Fisher Scientific Inc.
  • ISIN: US8835561023
  • Ticker: TMO
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 13, 2026, 5:31 p.m. CEST): EUR 591.40
  • NYSE move: minus 0.24 percent versus USD 662.24 on October 12, 2026
  • Market capitalization: USD 244.3 billion (as of October 13, 2026)
  • 52-week range: USD 435.27-694.33 (as of October 13, 2026)
  • P/E ratio: 35.51 (as of October 13, 2026)

Market context: Market report S&P 500.

More news and analyses on Thermo Fisher Scientific stock

Disclaimer...

en | US8835561023 | THERMO FISHER SCIENTIFIC INC. | boerse | 70315682 | bgmi